Medicine and Mortality in Mali: one health heroine's work to improve community health 🌍 MusoHealth womeninGH interview healthcare community MaternalHealth
Dr. Mariam CisséUrban Site CoordinatorMuso In this interview, we speak to Dr. Mariam Cissé about her recent Heroines of Health Award as well as her dedication to improving the health of her community in Mali. Please can you introduce yourself and tell us what inspired your career as a doctor? Born and raised in Mali, Dr. Mariam has dedicated her life to caring for the health of her community, particularly regarding child mortality.
You have recently been awarded a Heroine of Health Award by Women in Global Health for your contributions and achievements. Please can you tell us about the work you are involved with that led to this award? The organization I am currently working with is Muso, whose vision is to improve the health system through community health.
Since I started coordinating Muso's urban site, the wait time for women at the health center has decreased for access to prenatal health and family planning services. In 2022, in my intervention site, 63% of women attended antenatal care in their first trimester, compared to 36% nationally. You have devoted your career to improving maternal and child health outcomes, redefining what the Malian health system is capable of. How important was it to you to work in remote communities? We truly understand essential needs through contact with those who are most vulnerable.
Are you hopeful that with continued awareness and support for women in health, we will one day see these women taking on higher, better-paid roles? What would this mean for global equality? Yes, I am definitely hopeful, and thanks to initiatives such as the Heroines of Health award, women are encouraged and feel seen. Women will fight more and more for their rights because we have to know that no one else will fight this battle against inequality for us.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The impact of cardiovascular health and frailty on mortality for males and females across the life course - BMC MedicineBackground The effect of frailty and poor cardiovascular health on mortality for males and females is not fully elucidated. We investigated whether the combined burden of frailty and poor cardiovascular health is associated with all-cause and cardiovascular disease (CVD) mortality by sex and age. Methods We analyzed data of 35,207 non-institutionalized US residents aged 20–85 years old (mean age [standard deviation]: 46.6 [16.7 years], 51.4% female, 70.8% White, 10.3% Black, 13.2% Hispanic) from the National Health and Nutrition Examination Survey (1999–2015). Cardiovascular health was measured with the American Heart Association’s Life’s Simple 7 score (LS7). A 33-item frailty index (FI) was constructed to exclude cardiovascular health deficits. We grouped the FI into 0.1 increments (non-frail: FI | 0.10, very mildly frail: 0.1 ≤ FI | 0.20, mildly frail: 0.20 ≤ FI | 0.30, and moderately/severely frail: FI ≥ 0.30) and LS7 into tertiles (T1[poor]=0–7, T2[intermediate]=8-9, T3[ideal]=10–14). All-cause and CVD mortality data were analyzed up to 16 years. All regression models were stratified by sex. Results The average FI was 0.09 (SD 0.10); 29.6% were at least very mildly frail, and the average LS7 was 7.9 (2.3). Mortality from all-causes and CVD were 8.5% (4228/35,207) and 6.1% (2917/35,207), respectively. The median length of follow-up was 8.1 years. The combined burden of frailty and poor cardiovascular health on mortality risk varied according to age in males (FI*age interaction p=0.01; LS7*age interaction p | 0.001) but not in females. In females, poor FI and LS7 combined to predict all-cause and CVD mortality in a dose-response manner. All-cause and CVD mortality risk was greater for older males (60 and 70 years old) who were at least mildly frail and had intermediate cardiovascular health or worse (hazard ratio [lower/higher confidence interval ranges] range: all-cause mortality=2.02–5.30 [1.20–4.04, 3.15–6.94]; CVD-related mortality=2.22–7.16 [1.03–4.46, 4.49–
Read more »
Cristiano Ronaldo is wrong about being 'betrayed' - he just can't accept his own mortalityCristiano Ronaldo is wrong about being 'betrayed' - he just can't accept his own mortality ✒️ samcunningham for iPaperSport
Read more »
Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction - Nature MedicineIn this proof-of-concept prospective study, single-lead electrocardiograms obtained by smartwatches were able to identify individuals with left ventricular dysfunction, potentially serving as an early warning system for heart failure.
Read more »
Behind the Scenes of the Oncology & Precision Medicine Conferences 2022During the conference, we caught up with some of the speakers to learn more about their work, what they were presenting, and their thoughts about the future of Oncology and Precision Medicine.
Read more »
NI Protocol: Medicine supply still faces 'significant issue'Pharmaceutical firm tevapharmeurope said there are unresolved issues around medicine supplies and the protocol 💊 Brexit
Read more »
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms | NEJMMedicine and Society from The New England Journal of Medicine — Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
Read more »